Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 19, 2015
Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapyElizabeth Dudnik, Tali Siegal, Leor Zach, et al.Journal of Neuro-Oncology|September 23, 2015
MicroRNA as potential biomarkers in GlioblastomaZammam Areeb, Stanley S Stylli, Rachel Koldej, et al.International Journal of Clinical and Experimental Medicine|May 9, 2012
Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promotersDoron Amit, Imad J Matouk, Iris Lavon, et al.Journal of Neuro-Oncology|August 31, 2016
Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patientsTal Shahar, Avital Granit, Daniel Zrihan, et al.Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|November 3, 2023
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme PhenotypeYosef Laviv, Eilat Sapirstein, Andrew A Kanner, et al.Journal of Neurosurgery|January 23, 2016
Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumabTali Siegal, Hanna Charbit, Iddo Paldor, et al.Endocrine-Related Cancer|May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-RDavid J Gross, Gabriel Munter, Menachem Bitan, et al.Hematological Oncology|July 5, 2023
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtimeOsnat Bairey, Eyal Lebel, Chen Buxbaum, et al.Journal of Neurosurgery|November 26, 2014
Conflicting pathology reports: a diagnostic dilemmaTal Shahar, Uri Rozovski, Yuval Shapira, et al.Journal of Oncology|September 23, 2020
Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLCOmer Gal, Elizabeth Dudnik, Ofer Rotem, et al.Pageof 8